Rankings
▼
Calendar
XENE FY 2021 Earnings — Xenon Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena
XENE
Xenon Pharmaceuticals Inc.
$5B
FY 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$18M
-42.7% YoY
Gross Profit
$18M
100.0% margin
Operating Income
-$79M
-428.4% margin
Net Income
-$79M
-427.8% margin
EPS (Diluted)
$-1.77
Cash Flow
Operating Cash Flow
-$70M
Free Cash Flow
-$72M
Stock-Based Comp.
$10M
Balance Sheet
Total Assets
$572M
Total Liabilities
$22M
Stockholders' Equity
$550M
Cash & Equivalents
$176M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$18M
$32M
-42.7%
Gross Profit
$18M
$32M
-42.7%
Operating Income
-$79M
-$31M
-152.4%
Net Income
-$79M
-$29M
-173.5%
← Q4 2020
All Quarters
Q1 2021 →